Neos Therapeutics (NEOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 13,343 | 11,947 |
| Marketable Securities | 3,000 | 7,497 |
| Receivables | 367 | 454 |
| Inventories | 2,031 | 419 |
| Other current assets | 264 | 163 |
| TOTAL | $19,005 | $20,480 |
| Non-Current Assets | ||
| PPE Net | 5,831 | 7,039 |
| Intangibles | 18,167 | 12,332 |
| Other Non-Current Assets | 2,227 | 2,027 |
| TOTAL | $26,225 | $21,398 |
| Total Assets | $45,230 | $41,878 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 1,653 | 3,994 |
| Accounts payable and accrued liabilities | 1,257 | 973 |
| Accrued Expenses | 2,715 | 1,210 |
| TOTAL | $5,625 | $6,177 |
| Non-Current Liabilities | ||
| Long Term Debt | 23,121 | 16,454 |
| Other Non-Current Liabilities | 2,545 | 0 |
| TOTAL | $28,238 | $19,709 |
| Total Liabilities | $33,863 | $25,886 |
| Shareholders' Equity | ||
| Common Shares | 1 | 1 |
| Retained earnings | -83,614 | -59,462 |
| Other shareholders' equity | 90,149 | 70,836 |
| TOTAL | $11,367 | $15,992 |
| Total Liabilities And Equity | $45,230 | $41,878 |